Immune response and possible therapeutics in COVID-19

COVID-19 has emerged as a pandemic affecting about 213 countries in all the continents of the globe, resulting in more than 37.8 million individuals getting infected and over 1.08 million deaths worldwide, jeopardizing global human health and the economy. This presents an urgent need to develop ther...

Full description

Saved in:
Bibliographic Details
Published in:RSC advances 2021-01, Vol.11 (2), p.96-977
Main Authors: Dutta, Anindya, Roy, Ananya, Roy, Laboni, Chattopadhyay, Samit, Chatterjee, Subhrangsu
Format: Article
Language:English
Subjects:
Chemistry
Coronaviruses
COVID-19
Viral diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:COVID-19 has emerged as a pandemic affecting about 213 countries in all the continents of the globe, resulting in more than 37.8 million individuals getting infected and over 1.08 million deaths worldwide, jeopardizing global human health and the economy. This presents an urgent need to develop therapies that target the SARS-CoV2 virus specifically. This review aims at presenting the available information on the coronavirus disease 2019 along with various drugs that are having widespread use until a vaccine candidate is available to aid in the development of therapeutic strategies against COVID-19. While the world stands a witness to the havoc of COVID-19, we must continue our quest of exploring various small molecule drugs and biologics as therapeutic strategies to fight the pandemic.
ISSN:2046-2069
2046-2069
DOI:10.1039/d0ra08901j